Global Nucleic Acid Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Nucleic Acid Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the Nucleic Acid Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Nucleic Acid Vaccine market. Nucleic Acid Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nucleic Acid Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nucleic Acid Vaccine market.
A nucleic acid vaccine is to directly introduce an exogenous gene (DNA or RNA) encoding an antigen protein into an animal body cell, and synthesize the antigen protein through an expression system of a host cell to induce the host to produce an immune response to the antigen protein to achieve prevention And the purpose of treating the disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Nucleic Acid Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nucleic Acid Vaccine market. It may include historical data, market segmentation by Type (e.g., Preventive Nucleic Acid Vaccine, Therapeutic Vucleic Acid Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nucleic Acid Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nucleic Acid Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nucleic Acid Vaccine industry. This include advancements in Nucleic Acid Vaccine technology, Nucleic Acid Vaccine new entrants, Nucleic Acid Vaccine new investment, and other innovations that are shaping the future of Nucleic Acid Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nucleic Acid Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Nucleic Acid Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nucleic Acid Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nucleic Acid Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nucleic Acid Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nucleic Acid Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nucleic Acid Vaccine market.
Market Segmentation:
Nucleic Acid Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Nucleic Acid Vaccine market?
What factors are driving Nucleic Acid Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nucleic Acid Vaccine market opportunities vary by end market size?
How does Nucleic Acid Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Nucleic Acid Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the Nucleic Acid Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Nucleic Acid Vaccine market. Nucleic Acid Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nucleic Acid Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nucleic Acid Vaccine market.
A nucleic acid vaccine is to directly introduce an exogenous gene (DNA or RNA) encoding an antigen protein into an animal body cell, and synthesize the antigen protein through an expression system of a host cell to induce the host to produce an immune response to the antigen protein to achieve prevention And the purpose of treating the disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Nucleic Acid Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nucleic Acid Vaccine market. It may include historical data, market segmentation by Type (e.g., Preventive Nucleic Acid Vaccine, Therapeutic Vucleic Acid Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nucleic Acid Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nucleic Acid Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nucleic Acid Vaccine industry. This include advancements in Nucleic Acid Vaccine technology, Nucleic Acid Vaccine new entrants, Nucleic Acid Vaccine new investment, and other innovations that are shaping the future of Nucleic Acid Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nucleic Acid Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Nucleic Acid Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nucleic Acid Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nucleic Acid Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nucleic Acid Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nucleic Acid Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nucleic Acid Vaccine market.
Market Segmentation:
Nucleic Acid Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Preventive Nucleic Acid Vaccine
- Therapeutic Vucleic Acid Vaccine
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Moderna
- CureVac
- Inovio
- Sanofi
- GSK
- CNBG
- Hualan Bio
- Zhifei Shengwu
- Liaoning Chengda
- BioKangtai
- CanSinoBIO
- Walvax Biotechnology
- Fosun Pharma
What is the 10-year outlook for the global Nucleic Acid Vaccine market?
What factors are driving Nucleic Acid Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nucleic Acid Vaccine market opportunities vary by end market size?
How does Nucleic Acid Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Nucleic Acid Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Nucleic Acid Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Nucleic Acid Vaccine Segment by Type
2.2.1 Preventive Nucleic Acid Vaccine
2.2.2 Therapeutic Vucleic Acid Vaccine
2.3 Nucleic Acid Vaccine Sales by Type
2.3.1 Global Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Nucleic Acid Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Nucleic Acid Vaccine Sale Price by Type (2019-2024)
2.4 Nucleic Acid Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Nucleic Acid Vaccine Sales by Application
2.5.1 Global Nucleic Acid Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Nucleic Acid Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Nucleic Acid Vaccine Sale Price by Application (2019-2024)
3 GLOBAL NUCLEIC ACID VACCINE BY COMPANY
3.1 Global Nucleic Acid Vaccine Breakdown Data by Company
3.1.1 Global Nucleic Acid Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Nucleic Acid Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Nucleic Acid Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Nucleic Acid Vaccine Revenue by Company (2019-2024)
3.2.2 Global Nucleic Acid Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Nucleic Acid Vaccine Sale Price by Company
3.4 Key Manufacturers Nucleic Acid Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nucleic Acid Vaccine Product Location Distribution
3.4.2 Players Nucleic Acid Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NUCLEIC ACID VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Nucleic Acid Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Nucleic Acid Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Nucleic Acid Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nucleic Acid Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Nucleic Acid Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Nucleic Acid Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nucleic Acid Vaccine Sales Growth
4.4 APAC Nucleic Acid Vaccine Sales Growth
4.5 Europe Nucleic Acid Vaccine Sales Growth
4.6 Middle East & Africa Nucleic Acid Vaccine Sales Growth
5 AMERICAS
5.1 Americas Nucleic Acid Vaccine Sales by Country
5.1.1 Americas Nucleic Acid Vaccine Sales by Country (2019-2024)
5.1.2 Americas Nucleic Acid Vaccine Revenue by Country (2019-2024)
5.2 Americas Nucleic Acid Vaccine Sales by Type
5.3 Americas Nucleic Acid Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Vaccine Sales by Region
6.1.1 APAC Nucleic Acid Vaccine Sales by Region (2019-2024)
6.1.2 APAC Nucleic Acid Vaccine Revenue by Region (2019-2024)
6.2 APAC Nucleic Acid Vaccine Sales by Type
6.3 APAC Nucleic Acid Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nucleic Acid Vaccine by Country
7.1.1 Europe Nucleic Acid Vaccine Sales by Country (2019-2024)
7.1.2 Europe Nucleic Acid Vaccine Revenue by Country (2019-2024)
7.2 Europe Nucleic Acid Vaccine Sales by Type
7.3 Europe Nucleic Acid Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid Vaccine by Country
8.1.1 Middle East & Africa Nucleic Acid Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Nucleic Acid Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Nucleic Acid Vaccine Sales by Type
8.3 Middle East & Africa Nucleic Acid Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nucleic Acid Vaccine
10.3 Manufacturing Process Analysis of Nucleic Acid Vaccine
10.4 Industry Chain Structure of Nucleic Acid Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nucleic Acid Vaccine Distributors
11.3 Nucleic Acid Vaccine Customer
12 WORLD FORECAST REVIEW FOR NUCLEIC ACID VACCINE BY GEOGRAPHIC REGION
12.1 Global Nucleic Acid Vaccine Market Size Forecast by Region
12.1.1 Global Nucleic Acid Vaccine Forecast by Region (2025-2030)
12.1.2 Global Nucleic Acid Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nucleic Acid Vaccine Forecast by Type
12.7 Global Nucleic Acid Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna Nucleic Acid Vaccine Product Portfolios and Specifications
13.1.3 Moderna Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 CureVac
13.2.1 CureVac Company Information
13.2.2 CureVac Nucleic Acid Vaccine Product Portfolios and Specifications
13.2.3 CureVac Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CureVac Main Business Overview
13.2.5 CureVac Latest Developments
13.3 Inovio
13.3.1 Inovio Company Information
13.3.2 Inovio Nucleic Acid Vaccine Product Portfolios and Specifications
13.3.3 Inovio Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Inovio Main Business Overview
13.3.5 Inovio Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Nucleic Acid Vaccine Product Portfolios and Specifications
13.4.3 Sanofi Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK Nucleic Acid Vaccine Product Portfolios and Specifications
13.5.3 GSK Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
13.6 CNBG
13.6.1 CNBG Company Information
13.6.2 CNBG Nucleic Acid Vaccine Product Portfolios and Specifications
13.6.3 CNBG Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CNBG Main Business Overview
13.6.5 CNBG Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Nucleic Acid Vaccine Product Portfolios and Specifications
13.7.3 Hualan Bio Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 Zhifei Shengwu
13.8.1 Zhifei Shengwu Company Information
13.8.2 Zhifei Shengwu Nucleic Acid Vaccine Product Portfolios and Specifications
13.8.3 Zhifei Shengwu Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zhifei Shengwu Main Business Overview
13.8.5 Zhifei Shengwu Latest Developments
13.9 Liaoning Chengda
13.9.1 Liaoning Chengda Company Information
13.9.2 Liaoning Chengda Nucleic Acid Vaccine Product Portfolios and Specifications
13.9.3 Liaoning Chengda Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Liaoning Chengda Main Business Overview
13.9.5 Liaoning Chengda Latest Developments
13.10 BioKangtai
13.10.1 BioKangtai Company Information
13.10.2 BioKangtai Nucleic Acid Vaccine Product Portfolios and Specifications
13.10.3 BioKangtai Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 BioKangtai Main Business Overview
13.10.5 BioKangtai Latest Developments
13.11 CanSinoBIO
13.11.1 CanSinoBIO Company Information
13.11.2 CanSinoBIO Nucleic Acid Vaccine Product Portfolios and Specifications
13.11.3 CanSinoBIO Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 CanSinoBIO Main Business Overview
13.11.5 CanSinoBIO Latest Developments
13.12 Walvax Biotechnology
13.12.1 Walvax Biotechnology Company Information
13.12.2 Walvax Biotechnology Nucleic Acid Vaccine Product Portfolios and Specifications
13.12.3 Walvax Biotechnology Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Walvax Biotechnology Main Business Overview
13.12.5 Walvax Biotechnology Latest Developments
13.13 Fosun Pharma
13.13.1 Fosun Pharma Company Information
13.13.2 Fosun Pharma Nucleic Acid Vaccine Product Portfolios and Specifications
13.13.3 Fosun Pharma Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Fosun Pharma Main Business Overview
13.13.5 Fosun Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Nucleic Acid Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Nucleic Acid Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Nucleic Acid Vaccine Segment by Type
2.2.1 Preventive Nucleic Acid Vaccine
2.2.2 Therapeutic Vucleic Acid Vaccine
2.3 Nucleic Acid Vaccine Sales by Type
2.3.1 Global Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Nucleic Acid Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Nucleic Acid Vaccine Sale Price by Type (2019-2024)
2.4 Nucleic Acid Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Nucleic Acid Vaccine Sales by Application
2.5.1 Global Nucleic Acid Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Nucleic Acid Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Nucleic Acid Vaccine Sale Price by Application (2019-2024)
3 GLOBAL NUCLEIC ACID VACCINE BY COMPANY
3.1 Global Nucleic Acid Vaccine Breakdown Data by Company
3.1.1 Global Nucleic Acid Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Nucleic Acid Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Nucleic Acid Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Nucleic Acid Vaccine Revenue by Company (2019-2024)
3.2.2 Global Nucleic Acid Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Nucleic Acid Vaccine Sale Price by Company
3.4 Key Manufacturers Nucleic Acid Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nucleic Acid Vaccine Product Location Distribution
3.4.2 Players Nucleic Acid Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NUCLEIC ACID VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Nucleic Acid Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Nucleic Acid Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Nucleic Acid Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nucleic Acid Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Nucleic Acid Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Nucleic Acid Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nucleic Acid Vaccine Sales Growth
4.4 APAC Nucleic Acid Vaccine Sales Growth
4.5 Europe Nucleic Acid Vaccine Sales Growth
4.6 Middle East & Africa Nucleic Acid Vaccine Sales Growth
5 AMERICAS
5.1 Americas Nucleic Acid Vaccine Sales by Country
5.1.1 Americas Nucleic Acid Vaccine Sales by Country (2019-2024)
5.1.2 Americas Nucleic Acid Vaccine Revenue by Country (2019-2024)
5.2 Americas Nucleic Acid Vaccine Sales by Type
5.3 Americas Nucleic Acid Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Vaccine Sales by Region
6.1.1 APAC Nucleic Acid Vaccine Sales by Region (2019-2024)
6.1.2 APAC Nucleic Acid Vaccine Revenue by Region (2019-2024)
6.2 APAC Nucleic Acid Vaccine Sales by Type
6.3 APAC Nucleic Acid Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nucleic Acid Vaccine by Country
7.1.1 Europe Nucleic Acid Vaccine Sales by Country (2019-2024)
7.1.2 Europe Nucleic Acid Vaccine Revenue by Country (2019-2024)
7.2 Europe Nucleic Acid Vaccine Sales by Type
7.3 Europe Nucleic Acid Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid Vaccine by Country
8.1.1 Middle East & Africa Nucleic Acid Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Nucleic Acid Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Nucleic Acid Vaccine Sales by Type
8.3 Middle East & Africa Nucleic Acid Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nucleic Acid Vaccine
10.3 Manufacturing Process Analysis of Nucleic Acid Vaccine
10.4 Industry Chain Structure of Nucleic Acid Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nucleic Acid Vaccine Distributors
11.3 Nucleic Acid Vaccine Customer
12 WORLD FORECAST REVIEW FOR NUCLEIC ACID VACCINE BY GEOGRAPHIC REGION
12.1 Global Nucleic Acid Vaccine Market Size Forecast by Region
12.1.1 Global Nucleic Acid Vaccine Forecast by Region (2025-2030)
12.1.2 Global Nucleic Acid Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nucleic Acid Vaccine Forecast by Type
12.7 Global Nucleic Acid Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna Nucleic Acid Vaccine Product Portfolios and Specifications
13.1.3 Moderna Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 CureVac
13.2.1 CureVac Company Information
13.2.2 CureVac Nucleic Acid Vaccine Product Portfolios and Specifications
13.2.3 CureVac Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CureVac Main Business Overview
13.2.5 CureVac Latest Developments
13.3 Inovio
13.3.1 Inovio Company Information
13.3.2 Inovio Nucleic Acid Vaccine Product Portfolios and Specifications
13.3.3 Inovio Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Inovio Main Business Overview
13.3.5 Inovio Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Nucleic Acid Vaccine Product Portfolios and Specifications
13.4.3 Sanofi Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK Nucleic Acid Vaccine Product Portfolios and Specifications
13.5.3 GSK Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
13.6 CNBG
13.6.1 CNBG Company Information
13.6.2 CNBG Nucleic Acid Vaccine Product Portfolios and Specifications
13.6.3 CNBG Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CNBG Main Business Overview
13.6.5 CNBG Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Nucleic Acid Vaccine Product Portfolios and Specifications
13.7.3 Hualan Bio Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 Zhifei Shengwu
13.8.1 Zhifei Shengwu Company Information
13.8.2 Zhifei Shengwu Nucleic Acid Vaccine Product Portfolios and Specifications
13.8.3 Zhifei Shengwu Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zhifei Shengwu Main Business Overview
13.8.5 Zhifei Shengwu Latest Developments
13.9 Liaoning Chengda
13.9.1 Liaoning Chengda Company Information
13.9.2 Liaoning Chengda Nucleic Acid Vaccine Product Portfolios and Specifications
13.9.3 Liaoning Chengda Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Liaoning Chengda Main Business Overview
13.9.5 Liaoning Chengda Latest Developments
13.10 BioKangtai
13.10.1 BioKangtai Company Information
13.10.2 BioKangtai Nucleic Acid Vaccine Product Portfolios and Specifications
13.10.3 BioKangtai Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 BioKangtai Main Business Overview
13.10.5 BioKangtai Latest Developments
13.11 CanSinoBIO
13.11.1 CanSinoBIO Company Information
13.11.2 CanSinoBIO Nucleic Acid Vaccine Product Portfolios and Specifications
13.11.3 CanSinoBIO Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 CanSinoBIO Main Business Overview
13.11.5 CanSinoBIO Latest Developments
13.12 Walvax Biotechnology
13.12.1 Walvax Biotechnology Company Information
13.12.2 Walvax Biotechnology Nucleic Acid Vaccine Product Portfolios and Specifications
13.12.3 Walvax Biotechnology Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Walvax Biotechnology Main Business Overview
13.12.5 Walvax Biotechnology Latest Developments
13.13 Fosun Pharma
13.13.1 Fosun Pharma Company Information
13.13.2 Fosun Pharma Nucleic Acid Vaccine Product Portfolios and Specifications
13.13.3 Fosun Pharma Nucleic Acid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Fosun Pharma Main Business Overview
13.13.5 Fosun Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic Acid Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nucleic Acid Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Preventive Nucleic Acid Vaccine
Table 4. Major Players of Therapeutic Vucleic Acid Vaccine
Table 5. Global Nucleic Acid Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Nucleic Acid Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Nucleic Acid Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Nucleic Acid Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Nucleic Acid Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Nucleic Acid Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Nucleic Acid Vaccine Revenue by Application (2019-2024)
Table 13. Global Nucleic Acid Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Nucleic Acid Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Nucleic Acid Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Nucleic Acid Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Nucleic Acid Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Nucleic Acid Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Nucleic Acid Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Nucleic Acid Vaccine Producing Area Distribution and Sales Area
Table 21. Players Nucleic Acid Vaccine Products Offered
Table 22. Nucleic Acid Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nucleic Acid Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Nucleic Acid Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Nucleic Acid Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Nucleic Acid Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Nucleic Acid Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Nucleic Acid Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Nucleic Acid Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Nucleic Acid Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Nucleic Acid Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Nucleic Acid Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Nucleic Acid Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Nucleic Acid Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Nucleic Acid Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Nucleic Acid Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Nucleic Acid Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Nucleic Acid Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Nucleic Acid Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Nucleic Acid Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Nucleic Acid Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Nucleic Acid Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Nucleic Acid Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Nucleic Acid Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Nucleic Acid Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Nucleic Acid Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Nucleic Acid Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Nucleic Acid Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Nucleic Acid Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Nucleic Acid Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Nucleic Acid Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Nucleic Acid Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Nucleic Acid Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Nucleic Acid Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Nucleic Acid Vaccine
Table 58. Key Market Challenges & Risks of Nucleic Acid Vaccine
Table 59. Key Industry Trends of Nucleic Acid Vaccine
Table 60. Nucleic Acid Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nucleic Acid Vaccine Distributors List
Table 63. Nucleic Acid Vaccine Customer List
Table 64. Global Nucleic Acid Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Nucleic Acid Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Nucleic Acid Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Nucleic Acid Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Nucleic Acid Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Nucleic Acid Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Nucleic Acid Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Nucleic Acid Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Nucleic Acid Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Nucleic Acid Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Nucleic Acid Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Nucleic Acid Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Nucleic Acid Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Nucleic Acid Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Moderna Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Moderna Nucleic Acid Vaccine Product Portfolios and Specifications
Table 80. Moderna Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Moderna Main Business
Table 82. Moderna Latest Developments
Table 83. CureVac Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CureVac Nucleic Acid Vaccine Product Portfolios and Specifications
Table 85. CureVac Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. CureVac Main Business
Table 87. CureVac Latest Developments
Table 88. Inovio Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Inovio Nucleic Acid Vaccine Product Portfolios and Specifications
Table 90. Inovio Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Inovio Main Business
Table 92. Inovio Latest Developments
Table 93. Sanofi Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Nucleic Acid Vaccine Product Portfolios and Specifications
Table 95. Sanofi Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. GSK Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. GSK Nucleic Acid Vaccine Product Portfolios and Specifications
Table 100. GSK Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. CNBG Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. CNBG Nucleic Acid Vaccine Product Portfolios and Specifications
Table 105. CNBG Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. CNBG Main Business
Table 107. CNBG Latest Developments
Table 108. Hualan Bio Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Hualan Bio Nucleic Acid Vaccine Product Portfolios and Specifications
Table 110. Hualan Bio Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Hualan Bio Main Business
Table 112. Hualan Bio Latest Developments
Table 113. Zhifei Shengwu Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Zhifei Shengwu Nucleic Acid Vaccine Product Portfolios and Specifications
Table 115. Zhifei Shengwu Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Zhifei Shengwu Main Business
Table 117. Zhifei Shengwu Latest Developments
Table 118. Liaoning Chengda Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Liaoning Chengda Nucleic Acid Vaccine Product Portfolios and Specifications
Table 120. Liaoning Chengda Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Liaoning Chengda Main Business
Table 122. Liaoning Chengda Latest Developments
Table 123. BioKangtai Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. BioKangtai Nucleic Acid Vaccine Product Portfolios and Specifications
Table 125. BioKangtai Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. BioKangtai Main Business
Table 127. BioKangtai Latest Developments
Table 128. CanSinoBIO Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. CanSinoBIO Nucleic Acid Vaccine Product Portfolios and Specifications
Table 130. CanSinoBIO Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. CanSinoBIO Main Business
Table 132. CanSinoBIO Latest Developments
Table 133. Walvax Biotechnology Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Walvax Biotechnology Nucleic Acid Vaccine Product Portfolios and Specifications
Table 135. Walvax Biotechnology Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Walvax Biotechnology Main Business
Table 137. Walvax Biotechnology Latest Developments
Table 138. Fosun Pharma Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Fosun Pharma Nucleic Acid Vaccine Product Portfolios and Specifications
Table 140. Fosun Pharma Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Fosun Pharma Main Business
Table 142. Fosun Pharma Latest Developments
Table 1. Nucleic Acid Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nucleic Acid Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Preventive Nucleic Acid Vaccine
Table 4. Major Players of Therapeutic Vucleic Acid Vaccine
Table 5. Global Nucleic Acid Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Nucleic Acid Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Nucleic Acid Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Nucleic Acid Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Nucleic Acid Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Nucleic Acid Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Nucleic Acid Vaccine Revenue by Application (2019-2024)
Table 13. Global Nucleic Acid Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Nucleic Acid Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Nucleic Acid Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Nucleic Acid Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Nucleic Acid Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Nucleic Acid Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Nucleic Acid Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Nucleic Acid Vaccine Producing Area Distribution and Sales Area
Table 21. Players Nucleic Acid Vaccine Products Offered
Table 22. Nucleic Acid Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nucleic Acid Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Nucleic Acid Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Nucleic Acid Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Nucleic Acid Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Nucleic Acid Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Nucleic Acid Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Nucleic Acid Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Nucleic Acid Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Nucleic Acid Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Nucleic Acid Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Nucleic Acid Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Nucleic Acid Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Nucleic Acid Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Nucleic Acid Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Nucleic Acid Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Nucleic Acid Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Nucleic Acid Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Nucleic Acid Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Nucleic Acid Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Nucleic Acid Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Nucleic Acid Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Nucleic Acid Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Nucleic Acid Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Nucleic Acid Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Nucleic Acid Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Nucleic Acid Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Nucleic Acid Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Nucleic Acid Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Nucleic Acid Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Nucleic Acid Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Nucleic Acid Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Nucleic Acid Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Nucleic Acid Vaccine
Table 58. Key Market Challenges & Risks of Nucleic Acid Vaccine
Table 59. Key Industry Trends of Nucleic Acid Vaccine
Table 60. Nucleic Acid Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nucleic Acid Vaccine Distributors List
Table 63. Nucleic Acid Vaccine Customer List
Table 64. Global Nucleic Acid Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Nucleic Acid Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Nucleic Acid Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Nucleic Acid Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Nucleic Acid Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Nucleic Acid Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Nucleic Acid Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Nucleic Acid Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Nucleic Acid Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Nucleic Acid Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Nucleic Acid Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Nucleic Acid Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Nucleic Acid Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Nucleic Acid Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Moderna Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Moderna Nucleic Acid Vaccine Product Portfolios and Specifications
Table 80. Moderna Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Moderna Main Business
Table 82. Moderna Latest Developments
Table 83. CureVac Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CureVac Nucleic Acid Vaccine Product Portfolios and Specifications
Table 85. CureVac Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. CureVac Main Business
Table 87. CureVac Latest Developments
Table 88. Inovio Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Inovio Nucleic Acid Vaccine Product Portfolios and Specifications
Table 90. Inovio Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Inovio Main Business
Table 92. Inovio Latest Developments
Table 93. Sanofi Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Nucleic Acid Vaccine Product Portfolios and Specifications
Table 95. Sanofi Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. GSK Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. GSK Nucleic Acid Vaccine Product Portfolios and Specifications
Table 100. GSK Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. CNBG Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. CNBG Nucleic Acid Vaccine Product Portfolios and Specifications
Table 105. CNBG Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. CNBG Main Business
Table 107. CNBG Latest Developments
Table 108. Hualan Bio Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Hualan Bio Nucleic Acid Vaccine Product Portfolios and Specifications
Table 110. Hualan Bio Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Hualan Bio Main Business
Table 112. Hualan Bio Latest Developments
Table 113. Zhifei Shengwu Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Zhifei Shengwu Nucleic Acid Vaccine Product Portfolios and Specifications
Table 115. Zhifei Shengwu Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Zhifei Shengwu Main Business
Table 117. Zhifei Shengwu Latest Developments
Table 118. Liaoning Chengda Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Liaoning Chengda Nucleic Acid Vaccine Product Portfolios and Specifications
Table 120. Liaoning Chengda Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Liaoning Chengda Main Business
Table 122. Liaoning Chengda Latest Developments
Table 123. BioKangtai Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. BioKangtai Nucleic Acid Vaccine Product Portfolios and Specifications
Table 125. BioKangtai Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. BioKangtai Main Business
Table 127. BioKangtai Latest Developments
Table 128. CanSinoBIO Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. CanSinoBIO Nucleic Acid Vaccine Product Portfolios and Specifications
Table 130. CanSinoBIO Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. CanSinoBIO Main Business
Table 132. CanSinoBIO Latest Developments
Table 133. Walvax Biotechnology Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Walvax Biotechnology Nucleic Acid Vaccine Product Portfolios and Specifications
Table 135. Walvax Biotechnology Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Walvax Biotechnology Main Business
Table 137. Walvax Biotechnology Latest Developments
Table 138. Fosun Pharma Basic Information, Nucleic Acid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Fosun Pharma Nucleic Acid Vaccine Product Portfolios and Specifications
Table 140. Fosun Pharma Nucleic Acid Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Fosun Pharma Main Business
Table 142. Fosun Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nucleic Acid Vaccine
Figure 2. Nucleic Acid Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nucleic Acid Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Nucleic Acid Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Nucleic Acid Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Preventive Nucleic Acid Vaccine
Figure 10. Product Picture of Therapeutic Vucleic Acid Vaccine
Figure 11. Global Nucleic Acid Vaccine Sales Market Share by Type in 2023
Figure 12. Global Nucleic Acid Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Nucleic Acid Vaccine Consumed in Hospital
Figure 14. Global Nucleic Acid Vaccine Market: Hospital (2019-2024) & (K Units)
Figure 15. Nucleic Acid Vaccine Consumed in Clinic
Figure 16. Global Nucleic Acid Vaccine Market: Clinic (2019-2024) & (K Units)
Figure 17. Nucleic Acid Vaccine Consumed in Others
Figure 18. Global Nucleic Acid Vaccine Market: Others (2019-2024) & (K Units)
Figure 19. Global Nucleic Acid Vaccine Sales Market Share by Application (2023)
Figure 20. Global Nucleic Acid Vaccine Revenue Market Share by Application in 2023
Figure 21. Nucleic Acid Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global Nucleic Acid Vaccine Sales Market Share by Company in 2023
Figure 23. Nucleic Acid Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Nucleic Acid Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Nucleic Acid Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Nucleic Acid Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Nucleic Acid Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Nucleic Acid Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Nucleic Acid Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Nucleic Acid Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Nucleic Acid Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Nucleic Acid Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Nucleic Acid Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Nucleic Acid Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Nucleic Acid Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Nucleic Acid Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Nucleic Acid Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Nucleic Acid Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Nucleic Acid Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Nucleic Acid Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Nucleic Acid Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Nucleic Acid Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Nucleic Acid Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Nucleic Acid Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Nucleic Acid Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Nucleic Acid Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Nucleic Acid Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Nucleic Acid Vaccine
Figure 74. Industry Chain Structure of Nucleic Acid Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Nucleic Acid Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Nucleic Acid Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Nucleic Acid Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Nucleic Acid Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Nucleic Acid Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Nucleic Acid Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Nucleic Acid Vaccine
Figure 2. Nucleic Acid Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nucleic Acid Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Nucleic Acid Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Nucleic Acid Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Preventive Nucleic Acid Vaccine
Figure 10. Product Picture of Therapeutic Vucleic Acid Vaccine
Figure 11. Global Nucleic Acid Vaccine Sales Market Share by Type in 2023
Figure 12. Global Nucleic Acid Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Nucleic Acid Vaccine Consumed in Hospital
Figure 14. Global Nucleic Acid Vaccine Market: Hospital (2019-2024) & (K Units)
Figure 15. Nucleic Acid Vaccine Consumed in Clinic
Figure 16. Global Nucleic Acid Vaccine Market: Clinic (2019-2024) & (K Units)
Figure 17. Nucleic Acid Vaccine Consumed in Others
Figure 18. Global Nucleic Acid Vaccine Market: Others (2019-2024) & (K Units)
Figure 19. Global Nucleic Acid Vaccine Sales Market Share by Application (2023)
Figure 20. Global Nucleic Acid Vaccine Revenue Market Share by Application in 2023
Figure 21. Nucleic Acid Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global Nucleic Acid Vaccine Sales Market Share by Company in 2023
Figure 23. Nucleic Acid Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Nucleic Acid Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Nucleic Acid Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Nucleic Acid Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Nucleic Acid Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Nucleic Acid Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Nucleic Acid Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Nucleic Acid Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Nucleic Acid Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Nucleic Acid Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Nucleic Acid Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Nucleic Acid Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Nucleic Acid Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Nucleic Acid Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Nucleic Acid Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Nucleic Acid Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Nucleic Acid Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Nucleic Acid Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Nucleic Acid Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Nucleic Acid Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Nucleic Acid Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Nucleic Acid Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Nucleic Acid Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Nucleic Acid Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Nucleic Acid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Nucleic Acid Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Nucleic Acid Vaccine
Figure 74. Industry Chain Structure of Nucleic Acid Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Nucleic Acid Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Nucleic Acid Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Nucleic Acid Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Nucleic Acid Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Nucleic Acid Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Nucleic Acid Vaccine Revenue Market Share Forecast by Application (2025-2030)
